For the quarter ending 2025-12-31, TECH made $295,877K in revenue. $40,060K in net income. Net profit margin of 13.54%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net sales | 295,877 | 286,555 | 316,965 | 316,181 |
| Cost of sales | 104,600 | 98,443 | 118,152 | 101,625 |
| Gross margin | 191,277 | 188,112 | 198,813 | 214,556 |
| Selling, general and administrative | 113,691 | 116,213 | 196,640 | 151,269 |
| Research and development | 23,125 | 24,241 | 26,032 | 24,579 |
| Total operating expenses | 136,816 | 140,454 | 222,672 | 175,848 |
| Operating income | 54,461 | 47,658 | -23,859 | 38,708 |
| Interest expense | - | - | 2,178 | - |
| Interest income | - | - | 972 | - |
| Other non-operating income (expense), net | - | - | 2,208 | - |
| Other income (expense) | -3,677 | 333 | 1,001 | -434 |
| Earnings before income taxes | 50,784 | 47,991 | -22,858 | 38,274 |
| Income taxes | 12,775 | 9,806 | -5,180 | 15,686 |
| Net earnings | - | - | 18,350 | - |
| Net earnings | 38,009 | 38,185 | -17,678 | 22,588 |
| Foreign currency translation income (loss) | 2,762 | -2,850 | 22,953 | 5,311 |
| Unrealized gains (losses) on derivative instruments | -711 | -1,665 | -781 | -1,713 |
| Other comprehensive income (loss) | 2,051 | -4,515 | 22,172 | 3,598 |
| Other comprehensive income (loss) attributable to bio-techne | - | - | 22,172 | - |
| Comprehensive income | 40,060 | 33,670 | 4,494 | 26,186 |
| Earnings per share, basic | 0.24 | 0.25 | -0.1 | 0.14 |
| Earnings per share, diluted | 0.24 | 0.24 | -0.11 | 0.14 |
| Weighted average number of shares outstanding, basic | 155,839,000 | 155,464,000 | -316,813,000 | 157,372,000 |
| Weighted average number of shares outstanding, diluted | 156,999,000 | 156,362,000 | -320,968,000 | 158,944,000 |
BIO-TECHNE Corp (TECH)
BIO-TECHNE Corp (TECH)